News
Entertainment
Science & Technology
Life
Culture & Art
Hobbies
News
Entertainment
Science & Technology
Culture & Art
Hobbies
Orchestra BioMed’s Hypertension Device Wins FDA Breakthrough Designation - MedCity News
Orchestra BioMed’s hypertension treatment is the latest medical device to earn the FDA’s breakthrough designation. Medtronic has a commercialization deal with the company for the device, which uses a pacing algorithm to actively lower blood pressure in people with pacemakers.
Community-Driven Digital Solutions Can Transform Addiction Treatment and Ease the Burden on the Healthcare System - MedCity News
Technology has the power to revolutionize treatment, make it more widely available, provide additional patient insight, and ultimately, alleviate the strain on our already stressed healthcare system.
CRISPR Biotech Caribou Trims Pipeline and Cuts 32% of Staff to Focus on Two Cancer Cell Therapies - MedCity News
Caribou Biosciences’ restructuring narrows the biotech’s focus to two off-the-shelf cell therapies for blood cancers, whose key data readouts have been pushed out to the second half of 2025. It’s the CRISPR-editing company’s second cash-saving restructuring in the past year.
Trial Data Shows ‘IUD for Men’ Is Effective for 2 Years - MedCity News
Contraline released promising new trial data showing that its male contraceptive gel has demonstrated safety and efficacy in the first two trial participants to reach the two-year mark. The company is aiming to earn the product’s FDA approval by the end of 2028, according to CEO Kevin Eisenfrats.
Aiming for Earlier Intervention, Flagship Startup Etiome Emerges to Define ‘Biostages’ of Disease - MedCity News
Etiome’s precision medicine approach introduces a temporal component to treating disease — drugs developed specifically to treat disease at particular points in time even before symptoms show. The Flagship Pioneering startup’s approach offers the potential to prevent disease; in cases where disease is already present, Etiome aims to halt or even reverse it.
Advancing Patient & Planet Health Through Proper Healthcare Waste Management - MedCity News
By prioritizing sustainability-minded and compliant waste management in the workplace, healthcare leaders can advance patient and employee well-being, as well as environmental and fiscally responsible programs.
Improving Patient Trust with Digital Communication - MedCity News
Patients need tailored touchpoints throughout their health journey to stay engaged with their care plan. To do this effectively, healthcare organizations must leverage technology and digital communication strategies to drive and retain patient engagement and experience end-to-end.
Bristol Myers Squibb Schizophrenia Drug Fails Pivotal Test as an Add-On to Antipsychotics - MedCity News
Bristol Myers Squibb’s Cobenfy failed to outdistance a placebo in a Phase 3 test that evaluated the drug as an adjunct to antipsychotics in schizophrenia patients. Last September, the FDA approved Cobenfy as a standalone schizophrenia treatment.
There’s a Gap Between Healthcare Leaders’ AI Confidence and Their Ability to Scale - MedCity News
Healthcare leaders might be too confident about their AI readiness, according to new research. It showed that 70% of leaders feel at least somewhat confident in their organization’s AI governance frameworks, but only 15% report having scalable infrastructure in place.
The Critical Role Of Regional Vaccine Manufacturing In The Next Global Pandemic - MedCity News
A greater weight must be placed on vaccine manufacturing and distribution, both in the United States and worldwide, as we saw major imbalances in the world's response to Covid-19 that highlighted gaps in accessibility.
Roche Commits to $50B in U.S. Manufacturing and R&D Investments as Pharma Tariffs Loom - MedCity News
Roche said it will expand existing sites and construct new U.S. manufacturing and R&D infrastructure in areas such as gene therapy and cardiometabolic disease. The plans follow U.S. capital expenditure announcements from several big pharmaceutical companies.
Nursing Exodus Continues: 4 in 10 Plan to Leave by 2029 - MedCity News
The country’s nursing workforce has seen slight recovery since the pandemic, but burnout and stress continue to fuel high levels of turnover. New research reveals troubling retention trends — with more than 138,000 nurses having left the workforce since 2022 and 40% of nurses planning to leave the profession within five years.
Medicare Advantage CEO: My Baby is Ugly...(video) - MedCity News
Earlier this month Sachin Jain, CEO of SCAN Health Plan, a nonprofit Medicare Advantage company, provided some refreshing straight talk on what is wrong with MA while stressing that it is far better than traditional Medicare for seniors.
Clinician Adoption: How HealthTech Can Overcome Key Barriers - MedCity News
Even the most promising medical advancements struggle to take off in real-world settings without clinician buy-in. Here are some key factors that affect clinician adoption and ways healthtech companies can better position their innovations for success.
AstraZeneca & Daiichi Sankyo’s Enhertu Posts Positive Data as First-Line Breast Cancer Therapy - MedCity News
Enhertu is currently approved as a second-line treatment for HER2-positive metastatic breast cancer. The new results for the AstraZeneca and Daiichi Sankyo drug in the first-line setting are important because many patients do not live long enough to receive a second-line cancer therapy.
The Price is Wrong: We Need to Solve the Healthcare Insurance Transparency Crisis - MedCity News
In the U.S., many people still struggle to find care, book an appointment, confirm coverage, or get a clear answer on pricing. The impact goes beyond inconvenience, contributing to delayed diagnoses, increased anxiety, and financial stress that harms both patients and the healthcare system.
Women’s Health is Having Its Moment – It’s Time for the System to Catch Up - MedCity News
Too many women have experienced the impacts of living with gynecological conditions while feeling dismissed and struggling to get care. Women deserve better, and as we collectively challenge outdated norms, we are beginning to see improvement. Still, there’s much more work to be done.
Blockbuster Sanofi & Regeneron Drug Dupixent Notches FDA Nod for an Inflammatory Skin Disease - MedCity News
The FDA approved Sanofi and Regeneron Pharmaceuticals drug Dupixent as a treatment for the inflammatory skin disorder chronic spontaneous urticaria. The regulatory decision comes two years after the agency turned down an application for the biologic drug in this indication.
Drug-Gene Testing: Key to Safer Cancer Treatment - MedCity News
Although the healthcare industry has a long way to go before PGx testing for DPYD and other genes becomes widespread, it's encouraging that regulatory bodies and professional organizations are making recommendations and raising awareness among healthcare providers.
How Are Hospitals Bracing for Tariffs? - MedCity News
The Trump administration’s steep tariffs on Chinese imports are threatening to further destabilize hospitals’ bottom lines by driving up the cost of essential supplies and exacerbating already fragile supply chains. As providers prepare for higher expenses and potential shortages, experts warn that these policies could worsen care quality and force hospitals to make tough financial decisions — from cutting services to delaying tech upgrades.
Medical Device Right to Repair is the Wrong Approach - MedCity News
How can physicians and patients be confident enough that vendors entirely ignorant of the FDA process for repair and reporting can properly recalibrate life-saving machines? Is this really the right place to argue that “anyone can do it?”
How the Health Sector Can Change Vaccine Messaging Amid Rising Anti-Vaccine Sentiment - MedCity News
Robert F. Kennedy Jr.’s rise to become secretary of the Department of Health and Human Services has some concerned that anti-vaccine policies are coming. If the nation’s top public health agency pulls support of vaccination, other healthcare stakeholders will need to step up to fill the vaccine messaging void.
Why One Healthcare Founder Never Took Venture Capital - MedCity News
Randy Bolyga, founder CEO of RXNT, built his medical software company without venture capital, relying instead on SBA loans and a conservative, cash-positive growth strategy. He believes many venture capital-backed healthcare startups fail because they chase rapid growth without sustainable business models or a deep understanding of the market.
New Pregnancy App Launches to Support Mothers Through Birth and Beyond - MedCity News
Trellis Health emerged from stealth and announced $1.8 million in pre-seed funding. The platform helps women easily access and understand their medical records so they can make better health decisions during pregnancy and throughout their lives.